\begin{tabular}{@{\extracolsep{.3em}}lccD{.}{.}{1.2}D{.}{.}{1.2}D{.}{.}{1.2}D{.}{.}{1.2}D{.}{.}{2.2}D{.}{.}{1.2}D{.}{.}{2.2}}
\toprule
Method &\hspace{.2em}& $k$ &\multicolumn{1}{c}{$r$}&\multicolumn{1}{c}{$SE$}&
\multicolumn{1}{c}{$z$}&\multicolumn{1}{c}{$p$}&\multicolumn{2}{c}{95\% $CI$}& \multicolumn{1}{c}{$Q_W$}\\
\midrule
ATD &  & 38 & -0.10 & 0.05 & -0.98 & 0.03 & [-0.19, & -0.01] & 56.02 \\
CSF 5-HIAA &  & 34 & -0.06 & 0.04 & -0.88 & 0.16 & [-0.15, & 0.02] & 97.61 \\
Endocrine &  & 57 & -0.14 & 0.03 & -1.00 & 0.00 & [-0.20, & -0.07] & 137.57 \\
Pharmacological &  & 15 & -0.24 & 0.09 & -0.99 & 0.01 & [-0.40, & -0.07] & 16.76 \\
Overall &  & 144 & -0.12 & 0.02 & -1.00 & 0.00 & [-0.16, & -0.07] & 316.59 \\

\bottomrule\\
\multicolumn{10}{l}{\multirow{1}{5.63in}{\footnotesize{\emph{Note.}\hspace{.2em} %
Heterogeneity test for between-groups $Q_B$(3) = 4.16, $p$ = 0.244.   $k$ = number of independent effect sizes, $r$ = mean weighted effect size, $SE$ = standard error of the mean weighted effect size, $z$ = critical ratio test for the weighted correlation, $CI$ = 95\% confidence interval, $p$ = two-tailed probability of $z$, $Q_W$ = within-groups heterogeneity.
}}}\\\end{tabular}

